Search for: "CELGENE" Results 1 - 20 of 181
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Aug 2023, 4:01 pm by Zijian Han
 Celgene, the prior owner of the asserted patents, then sued Sandoz for infringing them, and Amgen was substituted as plaintiff when Celgene transferred Amgen these three patents. [read post]
10 Aug 2023, 11:48 am by Dennis Crouch
  The court quickly rejected this argument based upon its prior precedent in Celgene Corp. v. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
21 Apr 2023, 7:07 am by Jordan Duenckel
Celgene, the original plaintiff, brought this Hatch-Waxman suit, asserting that Sandoz’s generic product would infringe the ’638 and ’101 patents. [read post]
21 Jul 2022, 1:36 am by Kurt R. Karst
  Indeed, it’s a bit late for the PTO to be trying to “understand” how FDA’s and the PTO’s authorities and responsibilities overlap; and references to “exploring the policies surrounding the use of ‘skinny labels,’” use codes, and REMS seem pretty dated more than four years after the first GSK decision brought skinny labeling front and center, almost 13 years since the Caraco decision ordering correction of a patent use code, and 15 years… [read post]
18 Nov 2021, 9:19 am by Cinthia Macie
As a condition of Bristol Meyers Squibb’s acquisition of Celgene, the FTC required the drugmaker to divest the drug to Amgen , the FTC said. [read post]
9 Nov 2021, 9:31 pm by Patent Docs
The case arose over Celgene's multiple-myeloma drug pomalidomide (Pomalyst). [read post]
9 Nov 2021, 9:31 pm by Patent Docs
The case arose over Celgene's multiple-myeloma drug pomalidomide (Pomalyst). [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Celgene Corp. v. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Celgene Corp. v. [read post]
30 Sep 2021, 8:50 am by Tim De Chant
Initially, Celgene and another pharmaceutical company, GlaxoSmithKline, were intrigued by the promise of Theranos’ devices. [read post]